Article ID Journal Published Year Pages File Type
8243422 International Journal of Radiation Oncology*Biology*Physics 2007 8 Pages PDF
Abstract
Conclusions: I125 or Pd103 brachytherapy combined with supplemental EBRT results in excellent 15-year biochemical control. Different risk group classification schemes lead to different BRFS results in the high-risk group cohorts.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience
Authors
, , , , , , , ,